vs

Side-by-side financial comparison of ARMSTRONG WORLD INDUSTRIES INC (AWI) and Axsome Therapeutics, Inc. (AXSM). Click either name above to swap in a different company.

ARMSTRONG WORLD INDUSTRIES INC is the larger business by last-quarter revenue ($388.3M vs $196.0M, roughly 2.0× Axsome Therapeutics, Inc.). ARMSTRONG WORLD INDUSTRIES INC runs the higher net margin — 16.9% vs -14.6%, a 31.4% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 5.6%). ARMSTRONG WORLD INDUSTRIES INC produced more free cash flow last quarter ($62.2M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 9.1%).

Armstrong World Industries, Inc. is an international designer and manufacturer of wall and ceiling building materials based in Lancaster, Pennsylvania. As of 2014, AWI had 3,100 employees and a global manufacturing network of 17 facilities, down from 26, including nine plants dedicated to its WAVE joint venture, in 2012.

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.

AWI vs AXSM — Head-to-Head

Bigger by revenue
AWI
AWI
2.0× larger
AWI
$388.3M
$196.0M
AXSM
Growing faster (revenue YoY)
AXSM
AXSM
+59.4% gap
AXSM
65.0%
5.6%
AWI
Higher net margin
AWI
AWI
31.4% more per $
AWI
16.9%
-14.6%
AXSM
More free cash flow
AWI
AWI
$80.9M more FCF
AWI
$62.2M
$-18.7M
AXSM
Faster 2-yr revenue CAGR
AXSM
AXSM
Annualised
AXSM
61.7%
9.1%
AWI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AWI
AWI
AXSM
AXSM
Revenue
$388.3M
$196.0M
Net Profit
$65.5M
$-28.6M
Gross Margin
39.8%
Operating Margin
23.7%
-13.8%
Net Margin
16.9%
-14.6%
Revenue YoY
5.6%
65.0%
Net Profit YoY
5.3%
61.9%
EPS (diluted)
$1.51
$-0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AWI
AWI
AXSM
AXSM
Q4 25
$388.3M
$196.0M
Q3 25
$425.2M
$171.0M
Q2 25
$424.6M
$150.0M
Q1 25
$382.7M
$121.5M
Q4 24
$367.7M
$118.8M
Q3 24
$386.6M
$104.8M
Q2 24
$365.1M
$87.2M
Q1 24
$326.3M
$75.0M
Net Profit
AWI
AWI
AXSM
AXSM
Q4 25
$65.5M
$-28.6M
Q3 25
$86.3M
$-47.2M
Q2 25
$87.8M
$-48.0M
Q1 25
$69.1M
$-59.4M
Q4 24
$62.2M
$-74.9M
Q3 24
$76.9M
$-64.6M
Q2 24
$65.9M
$-79.3M
Q1 24
$59.9M
$-68.4M
Gross Margin
AWI
AWI
AXSM
AXSM
Q4 25
39.8%
Q3 25
42.0%
Q2 25
41.4%
Q1 25
39.2%
Q4 24
39.1%
Q3 24
42.4%
Q2 24
40.9%
Q1 24
38.1%
Operating Margin
AWI
AWI
AXSM
AXSM
Q4 25
23.7%
-13.8%
Q3 25
27.6%
-27.0%
Q2 25
29.0%
-24.5%
Q1 25
25.7%
-46.9%
Q4 24
22.3%
-61.1%
Q3 24
28.8%
-59.8%
Q2 24
26.0%
-89.5%
Q1 24
26.4%
-89.7%
Net Margin
AWI
AWI
AXSM
AXSM
Q4 25
16.9%
-14.6%
Q3 25
20.3%
-27.6%
Q2 25
20.7%
-32.0%
Q1 25
18.1%
-48.9%
Q4 24
16.9%
-63.1%
Q3 24
19.9%
-61.7%
Q2 24
18.0%
-91.0%
Q1 24
18.4%
-91.1%
EPS (diluted)
AWI
AWI
AXSM
AXSM
Q4 25
$1.51
$-0.55
Q3 25
$1.98
$-0.94
Q2 25
$2.01
$-0.97
Q1 25
$1.58
$-1.22
Q4 24
$1.41
$-1.54
Q3 24
$1.75
$-1.34
Q2 24
$1.50
$-1.67
Q1 24
$1.36
$-1.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AWI
AWI
AXSM
AXSM
Cash + ST InvestmentsLiquidity on hand
$112.7M
$322.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$900.7M
$88.3M
Total Assets
$1.9B
$689.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AWI
AWI
AXSM
AXSM
Q4 25
$112.7M
$322.9M
Q3 25
$90.1M
$325.3M
Q2 25
$81.1M
$303.0M
Q1 25
$82.8M
$300.9M
Q4 24
$79.3M
$315.4M
Q3 24
$73.7M
$327.3M
Q2 24
$73.6M
$315.7M
Q1 24
$69.6M
$331.4M
Stockholders' Equity
AWI
AWI
AXSM
AXSM
Q4 25
$900.7M
$88.3M
Q3 25
$889.2M
$73.7M
Q2 25
$837.8M
$73.1M
Q1 25
$793.4M
$53.2M
Q4 24
$757.1M
$57.0M
Q3 24
$717.0M
$92.9M
Q2 24
$669.0M
$102.9M
Q1 24
$626.8M
$144.0M
Total Assets
AWI
AWI
AXSM
AXSM
Q4 25
$1.9B
$689.8M
Q3 25
$1.9B
$669.3M
Q2 25
$1.9B
$639.8M
Q1 25
$1.9B
$596.7M
Q4 24
$1.8B
$568.5M
Q3 24
$1.8B
$561.5M
Q2 24
$1.8B
$548.2M
Q1 24
$1.7B
$545.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AWI
AWI
AXSM
AXSM
Operating Cash FlowLast quarter
$110.0M
$-18.7M
Free Cash FlowOCF − Capex
$62.2M
$-18.7M
FCF MarginFCF / Revenue
16.0%
-9.6%
Capex IntensityCapex / Revenue
12.3%
0.0%
Cash ConversionOCF / Net Profit
1.68×
TTM Free Cash FlowTrailing 4 quarters
$246.1M
$-93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AWI
AWI
AXSM
AXSM
Q4 25
$110.0M
$-18.7M
Q3 25
$122.9M
$1.0M
Q2 25
$81.6M
$-32.4M
Q1 25
$41.0M
$-43.4M
Q4 24
$86.6M
$-26.2M
Q3 24
$96.5M
$-18.6M
Q2 24
$57.3M
$-30.1M
Q1 24
$26.4M
$-53.5M
Free Cash Flow
AWI
AWI
AXSM
AXSM
Q4 25
$62.2M
$-18.7M
Q3 25
$100.3M
$988.0K
Q2 25
$61.7M
$-32.4M
Q1 25
$21.9M
$-43.7M
Q4 24
$57.8M
$-26.2M
Q3 24
$77.1M
$-18.7M
Q2 24
$37.4M
$-30.2M
Q1 24
$11.7M
$-53.6M
FCF Margin
AWI
AWI
AXSM
AXSM
Q4 25
16.0%
-9.6%
Q3 25
23.6%
0.6%
Q2 25
14.5%
-21.6%
Q1 25
5.7%
-36.0%
Q4 24
15.7%
-22.1%
Q3 24
19.9%
-17.9%
Q2 24
10.2%
-34.6%
Q1 24
3.6%
-71.4%
Capex Intensity
AWI
AWI
AXSM
AXSM
Q4 25
12.3%
0.0%
Q3 25
5.3%
0.0%
Q2 25
4.7%
0.0%
Q1 25
5.0%
0.3%
Q4 24
7.8%
0.0%
Q3 24
5.0%
0.1%
Q2 24
5.5%
0.1%
Q1 24
4.5%
0.1%
Cash Conversion
AWI
AWI
AXSM
AXSM
Q4 25
1.68×
Q3 25
1.42×
Q2 25
0.93×
Q1 25
0.59×
Q4 24
1.39×
Q3 24
1.25×
Q2 24
0.87×
Q1 24
0.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AWI
AWI

Distributors$183.0M47%
Architectural Specialties$143.7M37%
Home Centers$27.2M7%
Retailers And Other$21.7M6%
Direct Customers$12.7M3%

AXSM
AXSM

Segment breakdown not available.

Related Comparisons